Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Two China Biopharmas Hit with Accusations of Bribery

publication date: Sep 12, 2013
Two domestic China biopharmas were charged with bribing China doctors and government officials to increase sales of their products. China’s official TV network, CCTV, made the accusations against Sino Biopharmaceutical. Because of the wide-spread publicity, the price of the company’s Hong Kong-listed stock dropped as much as 25%. The company requested a trading halt when the shares were down 16%. The other company, Gan & Lee Pharma, is not publicly held, though it is planning to complete an IPO soon. More details....

Stock Symbol: (HK: 1177)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital